Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2025 Financial Results on May 12, 2025
Rhea-AI Summary
Quipt Home Medical, a leading U.S. based home medical equipment provider specializing in end-to-end respiratory care, has scheduled its fiscal Second quarter 2025 financial results announcement for May 12, 2025, after market close.
The company's leadership team, including CEO Gregory Crawford and CFO Hardik Mehta, will host a conference call for the investment community on May 13, 2025 at 10:00 a.m. ET. Investors can join via:
- Canada/US Toll Free: 1 (833) 752 3722
- International: 1 (647) 846 8549
A live webcast will be available through the investor section of Quipt's website at www.quipthomemedical.com.
Positive
- Dual-listed on major exchanges (NASDAQ and TSX), indicating strong market presence and liquidity
- Focus on end-to-end respiratory care suggests specialized market positioning
Negative
- None.
News Market Reaction – QIPT
On the day this news was published, QIPT declined 0.92%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
CINCINNATI, April 30, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal Second quarter 2025 financial results on Monday, May 12, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, May 13, 2025, at 10:00 a.m. (ET).
The call-in numbers for participants are:
| Canada/US Toll Free: | 1 (833) 752 3722 |
| International: | 1 (647) 846 8549 |
A live webcast of the call will be accessible via the investor section of the Company’s website through the following link: www.quipthomemedical.com.
ABOUT QUIPT HOME MEDICAL
The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services, and making life easier for the patient.
For further information please visit our website at www.quipthomemedical.com, or contact:
Cole Stevens
VP of Corporate Development
Quipt Home Medical Corp.
859-300-6455
cole.stevens@myquipt.com
Gregory Crawford
Chief Executive Officer
Quipt Home Medical Corp.
859-300-6455
investorinfo@myquipt.com